These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 24592071)

  • 1. Case report: Methotrexate-induced pericardial effusion.
    Dündar B; Karalök A; Ureyen I; Gündoğdu B; Oçalan R; Turan T; Boran N; Tulunay G; Köse MF
    J Turk Ger Gynecol Assoc; 2013; 14(1):48-9. PubMed ID: 24592071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive factors of relapse in low-risk gestational trophoblastic neoplasia patients successfully treated with methotrexate alone.
    Couder F; Massardier J; You B; Abbas F; Hajri T; Lotz JP; Schott AM; Golfier F
    Am J Obstet Gynecol; 2016 Jul; 215(1):80.e1-7. PubMed ID: 26829503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness and toxicity of first-line methotrexate chemotherapy in low-risk postmolar gestational trophoblastic neoplasia: The New England Trophoblastic Disease Center experience.
    Maestá I; Nitecki R; Horowitz NS; Goldstein DP; de Freitas Segalla Moreira M; Elias KM; Berkowitz RS
    Gynecol Oncol; 2018 Jan; 148(1):161-167. PubMed ID: 29092742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serosal complications of single-agent low-dose methotrexate used in gestational trophoblastic diseases: first reported case of methotrexate-induced peritonitis.
    Sharma S; Jagdev S; Coleman RE; Hancock BW; Lorigan PC
    Br J Cancer; 1999 Nov; 81(6):1037-41. PubMed ID: 10576662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment results of methotrexate and folinic acid as primary chemotherapy for nonmetastatic gestational trophoblastic neoplasia.
    Srisomboon J; Suprasert P; Phongnarisorn C; Charoenkwan K; Siriaree S; Cheewakriangkrai C; Tantipalakorn C; Kietpeerakool C
    J Med Assoc Thai; 2005 Jul; 88(7):886-90. PubMed ID: 16241014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Weekly intravenous methotrexate with folinic acid for nonmetastatic gestational trophoblastic neoplasia.
    Kwon JS; Elit L; Mazurka J; Moens F; Schmuck ML
    Gynecol Oncol; 2001 Aug; 82(2):367-70. PubMed ID: 11531296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of nonmetastatic gestational trophoblastic disease: results of methotrexate alone versus methotrexate--folinic acid.
    Smith EB; Weed JC; Tyrey L; Hammond CB
    Am J Obstet Gynecol; 1982 Sep; 144(1):88-92. PubMed ID: 6287843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Response to initial treatment of low and intermediate risk gestational trophoblastic disease with methotrexate and folinic acid.
    Tonanont M; Inthasorn P; Boriboonhirunsarn D; Wongthiraporn W; Suphanit I
    J Med Assoc Thai; 2005 Oct; 88(10):1349-54. PubMed ID: 16519378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Weekly methotrexate (50mg/m(2)) without dose escalation as a primary regimen for low-risk gestational trophoblastic neoplasia.
    Kang WD; Choi HS; Kim SM
    Gynecol Oncol; 2010 Jun; 117(3):477-80. PubMed ID: 20347479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methotrexate pneumonitis in a patient with gestational trophoblastic neoplasia.
    Agarwal M; Sharma KK; Deokar K; Bharti N
    Afr J Thorac Crit Care Med; 2022; 28(3):. PubMed ID: 36339108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First line chemotherapy in low risk gestational trophoblastic neoplasia.
    Alazzam M; Tidy J; Hancock BW; Osborne R
    Cochrane Database Syst Rev; 2009 Jan; (1):CD007102. PubMed ID: 19160319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does methotrexate (MTX) dosing in a 8-day MTX/FA regimen for the treatment of low-risk gestational trophoblastic neoplasia affect outcomes? The MITO-9 study.
    Mangili G; Cioffi R; Danese S; Frigerio L; Ferrandina G; Cormio G; Rabaiotti E; Scarfone G; Gadducci A; Bergamini A; Pisano C; Candiani M
    Gynecol Oncol; 2018 Dec; 151(3):449-452. PubMed ID: 30266260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ten year's experience with methotrexate and folinic acid as primary therapy for gestational trophoblastic disease.
    Berkowitz RS; Goldstein DP; Bernstein MR
    Gynecol Oncol; 1986 Jan; 23(1):111-8. PubMed ID: 3002916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methotrexate infusion and folinic acid as primary therapy for nonmetastatic and low-risk metastatic gestational trophoblastic tumors. 15 years of experience.
    Garrett AP; Garner EO; Goldstein DP; Berkowitz RS
    J Reprod Med; 2002 May; 47(5):355-62. PubMed ID: 12063874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secondary chemotherapy for high-risk gestational trophoblastic neoplasia.
    Lurain JR; Nejad B
    Gynecol Oncol; 2005 May; 97(2):618-23. PubMed ID: 15863169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relapse rates after two versus three consolidation courses of methotrexate in the treatment of low-risk gestational trophoblastic neoplasia.
    Lybol C; Sweep FC; Harvey R; Mitchell H; Short D; Thomas CM; Ottevanger PB; Savage PM; Massuger LF; Seckl MJ
    Gynecol Oncol; 2012 Jun; 125(3):576-9. PubMed ID: 22410329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methotrexate infusion and folinic acid in the primary therapy of nonmetastatic gestational trophoblastic tumors.
    Berkowitz RS; Goldstein DP; Bernstein MR
    Gynecol Oncol; 1990 Jan; 36(1):56-9. PubMed ID: 2153091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EP-EMA regimen (etoposide and cisplatin with etoposide, methotrexate, and dactinomycin) in a series of 18 women with gestational trophoblastic neoplasia.
    Han SN; Amant F; Leunen K; Devi UK; Neven P; Vergote I
    Int J Gynecol Cancer; 2012 Jun; 22(5):875-80. PubMed ID: 22635033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonmetastatic gestational trophoblastic disease. Weekly methotrexate compared with 8-day methotrexate-folinic acid.
    Gleeson NC; Finan MA; Fiorica JV; Robert WS; Hoffman MS; Wilson J
    Eur J Gynaecol Oncol; 1993; 14(6):461-5. PubMed ID: 7514124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The outcome of patients with low risk gestational trophoblastic neoplasia treated with single agent intramuscular methotrexate and oral folinic acid.
    Taylor F; Grew T; Everard J; Ellis L; Winter MC; Tidy J; Hancock BW; Coleman RE
    Eur J Cancer; 2013 Oct; 49(15):3184-90. PubMed ID: 23870384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.